Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert de Boysson

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Medicine|July 2, 2016
Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease patternHubert de Boysson, Marc Lambert, Eric Liozon, et al.
European Journal of Internal Medicine|September 4, 2017
Repetitive <sup>18</sup>F-FDG-PET/CT in patients with large-vessel giant-cell arteritis and controlled diseaseHubert de Boysson, Nicolas Aide, Eric Liozon, et al.
Clinical Rheumatology|November 27, 2025
Characteristics of patients with major relapse in giant cell arteritis: a multicenter case-control studyAlice Rubinsztajn, Simon Parreau, Laurent Sailler, et al.
Seminars in Arthritis and Rheumatism|November 6, 2022
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitisAnaël Dumont, Fabien Labombarda, Sophie Gallou, et al.
Journal of Clinical Medicine|November 25, 2023
Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014-2017 and 2018-2020)Hubert de Boysson, Anael Dumont, Paul Castan, et al.
Seminars in Arthritis and Rheumatism|March 10, 2021
Giant cell arteritis-related aortic dissection: A multicenter retrospective studyHubert de Boysson, Olivier Espitia, Maxime Samson, et al.
Blood|July 8, 2022
An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance databaseSégolène Fuentes, Basile Chrétien, Charles Dolladille, et al.
The Journal of Rheumatology|March 17, 2019
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell ArteritisAnael Dumont, Jean-Jacques Parienti, Claire Delmas, et al.
Medicine|December 1, 2016
Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center studyMathieu Vautier, Hubert de Boysson, Christian Creveuil, et al.
Seminars in Arthritis and Rheumatism|March 27, 2019
Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control studyEric Liozon, Claire Delmas, Stéphanie Dumonteil, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Medicine|July 2, 2016
Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease patternHubert de Boysson, Marc Lambert, Eric Liozon, et al.
European Journal of Internal Medicine|September 4, 2017
Repetitive <sup>18</sup>F-FDG-PET/CT in patients with large-vessel giant-cell arteritis and controlled diseaseHubert de Boysson, Nicolas Aide, Eric Liozon, et al.
Clinical Rheumatology|November 27, 2025
Characteristics of patients with major relapse in giant cell arteritis: a multicenter case-control studyAlice Rubinsztajn, Simon Parreau, Laurent Sailler, et al.
Seminars in Arthritis and Rheumatism|November 6, 2022
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitisAnaël Dumont, Fabien Labombarda, Sophie Gallou, et al.
Journal of Clinical Medicine|November 25, 2023
Evolution of the Therapeutic Management of Giant Cell Arteritis: Analysis of Real-Life Practices over Two Timeframes (2014-2017 and 2018-2020)Hubert de Boysson, Anael Dumont, Paul Castan, et al.
Seminars in Arthritis and Rheumatism|March 10, 2021
Giant cell arteritis-related aortic dissection: A multicenter retrospective studyHubert de Boysson, Olivier Espitia, Maxime Samson, et al.
Blood|July 8, 2022
An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance databaseSégolène Fuentes, Basile Chrétien, Charles Dolladille, et al.
The Journal of Rheumatology|March 17, 2019
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell ArteritisAnael Dumont, Jean-Jacques Parienti, Claire Delmas, et al.
Medicine|December 1, 2016
Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center studyMathieu Vautier, Hubert de Boysson, Christian Creveuil, et al.
Seminars in Arthritis and Rheumatism|March 27, 2019
Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control studyEric Liozon, Claire Delmas, Stéphanie Dumonteil, et al.
Pageof 13